CAPR vs GPN · $1.62B cap vs P/E 24, rev $6.29B
Capricor Therapeutics Inc (CAPR) versus Global Payments Inc (GPN) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. CAPR currently screens at market cap $1.62B.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
CAPR currently screens at market cap $1.62B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Not investment advice. Open the CAPR and GPN stock pages for the full models.
Not investment advice.